Drug Patents owned by Otsuka

1. Drug name - ABILIFY

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8642760 OTSUKA Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Sep, 2022

(a day ago)

US9359302 OTSUKA Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Sep, 2022

(a day ago)

US8580796 OTSUKA Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Sep, 2022

(a day ago)

CN1699346A OTSUKA Low Hygroscopic Aripiprazole Medicine And Preparation Method Thereof
Dec, 2007

(14 years ago)

CN101423493A OTSUKA Low Hygroscopic Aripiprazole Drug And Processes For Preparation Thereof
Jun, 2012

(10 years ago)

CN101574347B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101434574A OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For Preparation Thereof
Sep, 2019

(3 years ago)

CN101423492A OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For Preparation Thereof
Sep, 2019

(3 years ago)

CN101579344A OTSUKA Low Hygroscopic Aripiprazole Medicine And Preparation Method Thereof
Sep, 2019

(3 years ago)

CN101579343B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101579344B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101579343A OTSUKA Low-Hygroscopicity Aripiprazole Medicine And Preparation Method Thereof
Sep, 2019

(3 years ago)

CN101434573A OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For Preparation Thereof
Sep, 2019

(3 years ago)

CN101574347A OTSUKA Low Hygroscopic Forms Of Aripiprazole And Preparation Method Thereof
Sep, 2019

(3 years ago)

CN101423492B OTSUKA Aripiprazole Anhydride Crystal, Method For Producing The Same And Medicinal Preparation Containing The Same
Sep, 2019

(3 years ago)

CN103755632B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101434574B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101574348A OTSUKA Aripiprazole With Low Hygroscopicity And Preparation Method Thereof
Sep, 2019

(3 years ago)

CN101434573B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN103755632A OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101574348B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN1817882A OTSUKA Low Hygroscopic Aripiprazole Medicine And Preparation Method Thereof
Sep, 2022

(a day ago)

CN103288727B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

CN103288727A OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

CN1817882B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1330249A1 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Dec, 2020

(1 year, 9 months ago)

EP1330249B1 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Dec, 2020

(1 year, 9 months ago)

EP1419776A2 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1925308A1 OTSUKA Pharmaceutical Solid Oral Aripiprazole Preparation And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927357B1 OTSUKA Low Hygroscopic Aripiprazole (Crystal E) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927355A1 OTSUKA Low Hygroscopic Aripiprazole (Crystal F) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776B1 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1925308B1 OTSUKA Pharmaceutical Solid Oral Aripiprazole Preparation And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776B2 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927357A3 OTSUKA Low Hygroscopic Aripiprazole (Crystal E) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927355B1 OTSUKA Low Hygroscopic Aripiprazole (Crystal F) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927356A1 OTSUKA Low Hygroscopic Aripiprazole (Crystal D) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776A9 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927357A2 OTSUKA Low Hygroscopic Aripiprazole (Crystal E) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927356B1 OTSUKA Low Hygroscopic Aripiprazole (Crystal D) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776A3 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776A8 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6977257

(Pediatric)

OTSUKA Aripiprazole oral solution Oct, 2022

(27 days from now)

US8642760

(Pediatric)

OTSUKA Low hygroscopic aripiprazole drug substance and processes for the preparation thereof Mar, 2023

(5 months from now)

US8580796

(Pediatric)

OTSUKA Low hygroscopic aripiprazole drug substance and processes for the preparation thereof Mar, 2023

(5 months from now)

US9387182 OTSUKA Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders Dec, 2023

(1 year, 2 months from now)

US8017615 OTSUKA Low hygroscopic aripiprazole drug substance and processes for the preparation thereof Jun, 2024

(1 year, 8 months from now)

US7115587 OTSUKA Aripiprazole complex formulation and method Jul, 2024

(1 year, 9 months from now)

US7550445 OTSUKA Aripiprazole complex formulation and method Jul, 2024

(1 year, 9 months from now)

US8017615

(Pediatric)

OTSUKA Low hygroscopic aripiprazole drug substance and processes for the preparation thereof Dec, 2024

(2 years from now)

US7115587

(Pediatric)

OTSUKA Aripiprazole complex formulation and method Jan, 2025

(2 years from now)

US7550445

(Pediatric)

OTSUKA Aripiprazole complex formulation and method Jan, 2025

(2 years from now)

US9125939 OTSUKA Carbostyril derivatives and mood stabilizers for treating mood disorders Jul, 2026

(3 years from now)

US8759350 OTSUKA Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders Mar, 2027

(4 years from now)

Drugs and Companies using ARIPIPRAZOLE ingredient

Treatment: Adjunctive treatment of major depressive disorder (mdd); Treatment of schizophrenia; Acute treatment of manic and mixed episodes associated with bipolar i disorder

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
2MG TABLET;ORAL Prescription
5MG TABLET;ORAL Prescription
10MG TABLET;ORAL Prescription
15MG TABLET;ORAL Prescription
20MG TABLET;ORAL Prescription
30MG TABLET;ORAL Prescription

2. Drug name - ABILIFY MYCITE KIT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8580796 OTSUKA Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Sep, 2022

(a day ago)

US8642760 OTSUKA Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Sep, 2022

(a day ago)

US9359302 OTSUKA Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
Sep, 2022

(a day ago)

CN1699346A OTSUKA Low Hygroscopic Aripiprazole Medicine And Preparation Method Thereof
Dec, 2007

(14 years ago)

CN101423493A OTSUKA Low Hygroscopic Aripiprazole Drug And Processes For Preparation Thereof
Jun, 2012

(10 years ago)

CN101574347B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101434574A OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For Preparation Thereof
Sep, 2019

(3 years ago)

CN101423492A OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For Preparation Thereof
Sep, 2019

(3 years ago)

CN101579344A OTSUKA Low Hygroscopic Aripiprazole Medicine And Preparation Method Thereof
Sep, 2019

(3 years ago)

CN101579343B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101579344B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101579343A OTSUKA Low-Hygroscopicity Aripiprazole Medicine And Preparation Method Thereof
Sep, 2019

(3 years ago)

CN101434573A OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For Preparation Thereof
Sep, 2019

(3 years ago)

CN101574347A OTSUKA Low Hygroscopic Forms Of Aripiprazole And Preparation Method Thereof
Sep, 2019

(3 years ago)

CN101423492B OTSUKA Aripiprazole Anhydride Crystal, Method For Producing The Same And Medicinal Preparation Containing The Same
Sep, 2019

(3 years ago)

CN103755632B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101434574B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101574348A OTSUKA Aripiprazole With Low Hygroscopicity And Preparation Method Thereof
Sep, 2019

(3 years ago)

CN101434573B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN103755632A OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN101574348B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2019

(3 years ago)

CN1817882A OTSUKA Low Hygroscopic Aripiprazole Medicine And Preparation Method Thereof
Sep, 2022

(a day ago)

CN103288727B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

CN103288727A OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

CN1817882B OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1330249A1 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Dec, 2020

(1 year, 9 months ago)

EP1330249B1 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Dec, 2020

(1 year, 9 months ago)

EP1419776A2 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1925308A1 OTSUKA Pharmaceutical Solid Oral Aripiprazole Preparation And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927357B1 OTSUKA Low Hygroscopic Aripiprazole (Crystal E) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927355A1 OTSUKA Low Hygroscopic Aripiprazole (Crystal F) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776B1 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1925308B1 OTSUKA Pharmaceutical Solid Oral Aripiprazole Preparation And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776B2 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927357A3 OTSUKA Low Hygroscopic Aripiprazole (Crystal E) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927355B1 OTSUKA Low Hygroscopic Aripiprazole (Crystal F) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927356A1 OTSUKA Low Hygroscopic Aripiprazole (Crystal D) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776A9 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927357A2 OTSUKA Low Hygroscopic Aripiprazole (Crystal E) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1927356B1 OTSUKA Low Hygroscopic Aripiprazole (Crystal D) Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776A3 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

EP1419776A8 OTSUKA Low Hygroscopic Aripiprazole Drug Substance And Processes For The Preparation Thereof
Sep, 2022

(a day ago)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9387182 OTSUKA Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders Dec, 2023

(1 year, 2 months from now)

US8017615 OTSUKA Low hygroscopic aripiprazole drug substance and processes for the preparation thereof Jun, 2024

(1 year, 8 months from now)

US9125939 OTSUKA Carbostyril derivatives and mood stabilizers for treating mood disorders Jul, 2026

(3 years from now)

US7978064 OTSUKA Communication system with partial power source Sep, 2026

(3 years from now)

US8759350 OTSUKA Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders Mar, 2027

(4 years from now)

US9444503 OTSUKA Active signal processing personal health signal receivers Nov, 2027

(5 years from now)

US9119554 OTSUKA Pharma-informatics system Dec, 2028

(6 years from now)

US9258035 OTSUKA Multi-mode communication ingestible event markers and systems, and methods of using the same Mar, 2029

(6 years from now)

US9060708 OTSUKA Multi-mode communication ingestible event markers and systems, and methods of using the same Mar, 2029

(6 years from now)

US8674825 OTSUKA Pharma-informatics system Apr, 2029

(6 years from now)

US8956288 OTSUKA In-body power source having high surface area electrode Jul, 2029

(6 years from now)

US10441194 OTSUKA Ingestible event marker systems Jul, 2029

(6 years from now)

US8945005 OTSUKA Controlled activation ingestible identifier Aug, 2029

(6 years from now)

US9433371 OTSUKA In-body device with virtual dipole signal amplification Sep, 2029

(6 years from now)

US8718193 OTSUKA Active signal processing personal health signal receivers Dec, 2029

(7 years from now)

US9149577 OTSUKA Body-associated receiver and method Dec, 2029

(7 years from now)

US8847766 OTSUKA Pharma-informatics system Mar, 2030

(7 years from now)

US8545402 OTSUKA Highly reliable ingestible event markers and methods for using the same Apr, 2030

(7 years from now)

US8114021 OTSUKA Body-associated receiver and method Jun, 2030

(7 years from now)

US9941931 OTSUKA System for supply chain management Nov, 2030

(8 years from now)

US8961412 OTSUKA In-body device with virtual dipole signal amplification Nov, 2030

(8 years from now)

US8258962 OTSUKA Multi-mode communication ingestible event markers and systems, and methods of using the same Nov, 2030

(8 years from now)

US8547248 OTSUKA Implantable zero-wire communications system Dec, 2030

(8 years from now)

US11229378 OTSUKA Communication system with enhanced partial power source and method of manufacturing same Jul, 2031

(8 years from now)

US9320455 OTSUKA Highly reliable ingestible event markers and methods for using the same Dec, 2031

(9 years from now)

US10517507 OTSUKA Communication system with enhanced partial power source and method of manufacturing same Jun, 2032

(9 years from now)

US9268909 OTSUKA Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device Oct, 2033

(11 years from now)

Drugs and Companies using ARIPIPRAZOLE ingredient

Treatment: Adjunctive treatment of major depressive disorder (mdd); Acute treatment of manic and mixed episodes associated with bipolar i disorder; Method of using a receiver to identify a signal from a tablet embedded with a sensor that communicates information through the body of a patient; Method of using a receiver to receive a signal from a tablet embedded with a sensor that communicates information through the body of a patient; Method of using a tablet embedded with a sensor that communicates information via a signal through the body of a patient to a receiver; Method of using a logic circuit to stabilize battery voltage supplied to a sensor embedded with a tablet and that communicates information via a signal through the body of a patient to a receiver

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
2MG TABLET;ORAL Prescription
5MG TABLET;ORAL Prescription
10MG TABLET;ORAL Prescription
15MG TABLET;ORAL Prescription
20MG TABLET;ORAL Prescription
30MG TABLET;ORAL Prescription

3. Drug name - INQOVI

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US9567363 OTSUKA Certain compounds, compositions and methods
Oct, 2028

(6 years from now)

US8268800 OTSUKA Certain compounds, compositions and methods
Aug, 2030

(7 years from now)

CN101827856B OTSUKA 2'-Fluoro--2'-Deoxy-Tetrahydro-Uridine As Cytosine Nucleoside Deaminase Inhibitor
Oct, 2028

(6 years from now)

CN101827856A OTSUKA 2'-Fluoro-2'-Deoxytetrahydrouridines As Cytidine Deaminase Inhibitors
Oct, 2028

(6 years from now)

IN201003209P1 OTSUKA 2 '-Fluoro-2 ' -Deoxytetrahydrouridines As Cytidine Deaminase Inhibitors
Oct, 2028

(6 years from now)

IN286739B OTSUKA 2'-Flu0R0-2'-Deoxytetrahydrouridines As Cytidine Deaminase Inhibitors
Oct, 2028

(6 years from now)

EP2207786B1 OTSUKA 2'-Fluoro-2'-Deoxytetrahydrouridines As Cytidine Deaminase Inhibitors
Oct, 2028

(6 years from now)

EP2447272B1 OTSUKA 2'-Fluoro-2'-Deoxytetrahydrouridines As Cytidine Deaminase Inhibitors
Oct, 2028

(6 years from now)

EP2207786A1 OTSUKA 2'-Fluoro-2'-Deoxytetrahydrouridines As Cytidine Deaminase Inhibitors
Oct, 2028

(6 years from now)

EP2447272A1 OTSUKA 2'-Fluoro-2'-Deoxytetrahydrouridines As Cytidine Deaminase Inhibitors
Oct, 2028

(6 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8618075 OTSUKA Certain compounds, compositions and methods Oct, 2028

(6 years from now)

Drugs and Companies using CEDAZURIDINE; DECITABINE ingredient

Treatment: Method for inhibiting cytidine deaminase by administering cedazuridine; method for inhibiting degradation of a cda substrate by administering cedazuridine

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
100MG;35MG TABLET;ORAL Prescription

4. Drug name - JYNARQUE

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8501730 OTSUKA Process for preparing benzazepine compounds or salts thereof
Sep, 2026

(3 years from now)

CN102219741B OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

CN102219741A OTSUKA For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

CN102746229A OTSUKA Method For Preparing Benzazepine Compound Or Salt Thereof
Sep, 2026

(3 years from now)

CN101967107B OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

CN102746229B OTSUKA For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

CN101273017A OTSUKA Method For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

CN101273017B OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

CN101967107A OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

IN257529B OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

IN201205750P1 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

IN201205723P1 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

IN290221B OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

IN293124B OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

IN200801507P1 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

EP1919874B1 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

EP2261215B1 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

EP1919874A2 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

EP2251319A3 OTSUKA Process For Preparing Derivatives Of Benzoic Acid
Sep, 2026

(3 years from now)

EP2261215A1 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

EP2251319B1 OTSUKA Process For Preparing Derivatives Of Benzoic Acid
Sep, 2026

(3 years from now)

EP2251319A2 OTSUKA Process For Preparing Derivatives Of Benzoic Acid
Sep, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10905694 OTSUKA Pharmaceutical solid preparation comprising benzazepines and production method thereof Apr, 2030

(7 years from now)

Drugs and Companies using TOLVAPTAN ingredient

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
15MG TABLET;ORAL Prescription
30MG TABLET;ORAL Prescription
45MG TABLET;ORAL Prescription
60MG TABLET;ORAL Prescription
90MG TABLET;ORAL Prescription

5. Drug name - REXULTI

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7888362 OTSUKA Piperazine-substituted benzothiophenes for treatment of mental disorders
Apr, 2026

(3 years from now)

USRE48059 OTSUKA Piperazine-substituted benzothiophenes for treatment of mental disorders
Dec, 2028

(6 years from now)

CN101155804B OTSUKA For Treating Mental Disease Piperazine Substituted Benzothiophene
Apr, 2026

(3 years from now)

CN101155804A OTSUKA Piperazine-Substituted Benzothiophenes For Treatment Of Mental Disorders
Apr, 2026

(3 years from now)

IN251204B OTSUKA A Heterocyclic Compound Represented By The Formula(1)
Apr, 2026

(3 years from now)

IN200707041P1 OTSUKA Piperazine-Substituted Benzothiophenes For Treatment Of Mental Disorders
Apr, 2026

(3 years from now)

EP1869025A1 OTSUKA Piperazine-Substituted Benzothiophenes For Treatment Of Mental Disorders
Apr, 2026

(3 years from now)

EP1869025B1 OTSUKA Piperazine-Substituted Benzothiophenes For Treatment Of Mental Disorders
Apr, 2026

(3 years from now)

EP1869025B3 OTSUKA Piperazine-Substituted Benzothiophenes For Treatment Of Mental Disorders
Apr, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9839637 OTSUKA Piperazine-substituted benzothiophenes for treatment of mental disorders Apr, 2026

(3 years from now)

US8618109 OTSUKA Piperazine-substituted benzothiophenes for treatment of mental disorders Apr, 2026

(3 years from now)

US8349840 OTSUKA Piperazine-substituted benzothiophenes for treatment of mental disorders Apr, 2026

(3 years from now)

US10307419 OTSUKA Tablet comprising 7-[4-(4-benzo[b]thiopen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt thereof Oct, 2032

(10 years from now)

Drugs and Companies using BREXPIPRAZOLE ingredient

Treatment: Adjunctive treatment of major depressive disorder (mdd); treatment of schizophrenia; treatment of schizophrenia in adults and pediatric patients ages 13 years and older; Treatment of schizophrenia; treatment of schizophrenia in adults and pediatric patients ages 13 years and older; Adjunctive treatment of major depressive disorder (mdd)

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
0.25MG TABLET;ORAL Prescription
0.5MG TABLET;ORAL Prescription
1MG TABLET;ORAL Prescription
2MG TABLET;ORAL Prescription
3MG TABLET;ORAL Prescription
4MG TABLET;ORAL Prescription

6. Drug name - SAMSCA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8501730 OTSUKA Process for preparing benzazepine compounds or salts thereof
Sep, 2026

(3 years from now)

CN102219741B OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

CN102219741A OTSUKA For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

CN102746229A OTSUKA Method For Preparing Benzazepine Compound Or Salt Thereof
Sep, 2026

(3 years from now)

CN101967107B OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

CN102746229B OTSUKA For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

CN101273017A OTSUKA Method For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

CN101273017B OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

CN101967107A OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

IN257529B OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

IN201205750P1 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

IN201205723P1 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

IN290221B OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

IN293124B OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

IN200801507P1 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

EP1919874B1 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

EP2261215B1 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

EP1919874A2 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

EP2251319A3 OTSUKA Process For Preparing Derivatives Of Benzoic Acid
Sep, 2026

(3 years from now)

EP2261215A1 OTSUKA Process For Preparing Benzazepine Compounds Or Salts Thereof
Sep, 2026

(3 years from now)

EP2251319B1 OTSUKA Process For Preparing Derivatives Of Benzoic Acid
Sep, 2026

(3 years from now)

EP2251319A2 OTSUKA Process For Preparing Derivatives Of Benzoic Acid
Sep, 2026

(3 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10905694 OTSUKA Pharmaceutical solid preparation comprising benzazepines and production method thereof Apr, 2030

(7 years from now)

Drugs and Companies using TOLVAPTAN ingredient

Treatment: NA

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
15MG TABLET;ORAL Prescription
30MG TABLET;ORAL Prescription
60MG TABLET;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.